Stock concentration risks highlight need for diversity

GLOBAL INCOME

clock • 4 min read

The UK market is as skewed and concentrated as ever in a small number of large names, but Ross Hollyman, fund manager at Sabre Fund Management, argues bigger returns with less risk are available globally.

With bond yields at such low levels – UK 10-year gilts are at 2.7% currently – they offer little protection against unanticipated future inflation. With the recent rapid acceleration in the housing market, it cannot be long before UK base rates edge up from historically low levels. While a flattening yield curve may offer some price protection to holders of longer dated instruments, it is difficult to see any value in bonds at these levels. Bonds offer certainty of money returns in the short term, but such security is illusory to (most) investors with longer-term ‘real’ liabilities. I...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot